share_log

Aspira Womens Health Analyst Ratings

Benzinga ·  Aug 22, 2023 08:45
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/22/2023 102.9% Alliance Global Partners → $5.6 Initiates Coverage On → Buy
05/17/2023 63.04% Cantor Fitzgerald $2 → $4.5 Maintains Neutral
01/20/2023 -27.54% Cantor Fitzgerald $3 → $2 Downgrades Overweight → Neutral
03/29/2021 334.78% Truist Securities → $12 Initiates Coverage On → Buy
01/29/2021 262.32% Cantor Fitzgerald → $10 Initiates Coverage On → Overweight
10/30/2020 William Blair Initiates Coverage On → Outperform

What is the target price for Aspira Womens Health (AWH)?

The latest price target for Aspira Womens Health (NASDAQ: AWH) was reported by Alliance Global Partners on August 22, 2023. The analyst firm set a price target for $5.60 expecting AWH to rise to within 12 months (a possible 102.90% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Aspira Womens Health (AWH)?

The latest analyst rating for Aspira Womens Health (NASDAQ: AWH) was provided by Alliance Global Partners, and Aspira Womens Health initiated their buy rating.

When is the next analyst rating going to be posted or updated for Aspira Womens Health (AWH)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspira Womens Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspira Womens Health was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.

Is the Analyst Rating Aspira Womens Health (AWH) correct?

While ratings are subjective and will change, the latest Aspira Womens Health (AWH) rating was a initiated with a price target of $0.00 to $5.60. The current price Aspira Womens Health (AWH) is trading at is $2.76, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment